Refine by
237 results found
-
Hope Starts With Us: Criminal Justice Awareness Month
On this podcast, leaders from NAMI (the National Alliance on Mental Illness) bring important mental health topics to light, one conversation at a time. Hope starts with us sharing our stories. Hope starts with us breaking the stigma. Hope starts with us sharing resources and practical advice.
-
Letter to Congressional Committee Leadership on Mental Health Funding and Research and Innovation
Letter encouraging Congress to support robust FY2025 funding of at least $740 million for the BRAIN Initiative. -
Letter to Congressional Committee Leadership on Mental Health Funding and Research and Innovation
Letter to Appropriations Committee leadership requesting $5 million for the FDA’s Neurology Drug Program to advance discoveries in all areas of brain health. -
Hope Starts With Us: Living with Bipolar Disorder
March 30 is World Bipolar Day, and NAMI CEO Daniel H. Gillison, Jr. is chatting with speaker Gabe Howard, who hosts the podcasts “Inside Mental Health” and “Inside Bipolar,” about living a full life with bipolar disorder.
-
Racial Disparities in Schizophrenia Treatment with Clozapine
Despite the efficacy of the antipsychotic clozapine in treating schizophrenia, research suggests that its use is somewhat limited. This study investigates the role of demographic factors in this discrepancy.
-
Types of Jail-Based Mental Health Providers and Service Engagement after Re-Entry
After incarceration, it can be extremely difficult for people to stay connected to mental health services. A new study explores how different types of jail-based mental health providers may affect service engagement following release.
-
Regulatory Comment to NCQA on Maternal Mental Health and Research and Treatment Innovation
Comment in response to the National Committee for Quality Assurance (NCQA)’s 2024 request for public comment on HEDIS Perinatal Depression Screening Measures, urging NCQA to add anxiety screening to the measures, require mandatory reporting of the measures, and exclude screening by insurer/health plan staff. -
Regulatory Comment to NCQA on Crisis Services and Research and Treatment Innovation
Regulatory comment supporting the NCQA’s Proposed Changes to Existing HEDIS Measures: Follow-Up After Emergency Department Visit for Mental Illness (FUM) and Follow-Up After Hospitalization for Mental Illness (FUH), and providing additional recommendations to strengthen the measures, including guidance on follow-up care. -
Mental Illness And Substance Use During Pregnancy Rising
Mental illness and substance use during pregnancy may lead to adverse maternal and birth outcomes, and recent research highlights concerning trends for both risk factors. Based on analysis of 2012-2021 National Survey on Drug Use and Health data, the prevalence of any mental illness (AMI) and serious mental illness (SMI) among pregnant individuals has increased over the past decade, and the use of two or more substances (tobacco, alcohol or marijuana) has increased disproportionately among those with SMI. The researchers suggest compassionate, tailored strategies to best serve pregnant individuals with co-occurring mental illness and substance use. -
Letter to Congressional Committee Leadership on Child and Adolescent Mental Health and Research and Treatment Innovation
Letter asking Senate HELP Committee to include the Preventing Adverse Childhood Experiences (PACE) Act in its reauthorization of the SUPPORT for Patients and Communities Act.